• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation.代谢型谷氨酸受体 3 和β-肾上腺素能受体的共激活调节环 AMP 和长时程增强,并破坏记忆再巩固。
Neuropsychopharmacology. 2017 Dec;42(13):2553-2566. doi: 10.1038/npp.2017.136. Epub 2017 Jun 30.
2
Activation of Group II Metabotropic Glutamate Receptors Promotes LTP Induction at Schaffer Collateral-CA1 Pyramidal Cell Synapses by Priming NMDA Receptors.II型代谢型谷氨酸受体的激活通过启动NMDA受体促进在海马体Schaffer侧支-CA1锥体细胞突触处的长时程增强诱导。
J Neurosci. 2016 Nov 9;36(45):11521-11531. doi: 10.1523/JNEUROSCI.1519-16.2016.
3
β-Adrenergic Receptors/Epac Signaling Increases the Size of the Readily Releasable Pool of Synaptic Vesicles Required for Parallel Fiber LTP.β-肾上腺素能受体/Epac 信号增加了用于平行纤维 LTP 的突触囊泡的易释放池的大小。
J Neurosci. 2020 Nov 4;40(45):8604-8617. doi: 10.1523/JNEUROSCI.0716-20.2020. Epub 2020 Oct 12.
4
Novel glial-neuronal signalling by coactivation of metabotropic glutamate and beta-adrenergic receptors in rat hippocampus.大鼠海马体中代谢型谷氨酸受体和β-肾上腺素能受体共同激活产生的新型神经胶质-神经元信号传导
J Physiol. 1996 Aug 1;494 ( Pt 3)(Pt 3):743-55. doi: 10.1113/jphysiol.1996.sp021529.
5
Orexin A induces bidirectional modulation of synaptic plasticity: Inhibiting long-term potentiation and preventing depotentiation.食欲素A诱导突触可塑性的双向调节:抑制长时程增强并防止去增强。
Neuropharmacology. 2016 Aug;107:168-180. doi: 10.1016/j.neuropharm.2016.03.005. Epub 2016 Mar 7.
6
Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.使用 FLIPR 技术对原代皮质神经元培养物中的内源性 II 型代谢型谷氨酸受体进行药理学分析。
Neuropharmacology. 2013 Mar;66:264-73. doi: 10.1016/j.neuropharm.2012.05.023. Epub 2012 May 30.
7
A cyclic AMP-dependent form of associative synaptic plasticity induced by coactivation of beta-adrenergic receptors and metabotropic glutamate receptors in rat hippocampus.β-肾上腺素能受体和代谢型谷氨酸受体在大鼠海马体中共同激活所诱导的一种环磷酸腺苷依赖性的联合突触可塑性。
J Neurosci. 1994 May;14(5 Pt 2):3310-8. doi: 10.1523/JNEUROSCI.14-05-03310.1994.
8
Control of βAR- and N-methyl-D-aspartate (NMDA) Receptor-Dependent cAMP Dynamics in Hippocampal Neurons.海马神经元中β肾上腺素能受体(βAR)和N-甲基-D-天冬氨酸(NMDA)受体依赖性环磷酸腺苷(cAMP)动力学的调控
PLoS Comput Biol. 2016 Feb 22;12(2):e1004735. doi: 10.1371/journal.pcbi.1004735. eCollection 2016 Feb.
9
Activation of Metabotropic Glutamate Receptor 7 Is Required for Induction of Long-Term Potentiation at SC-CA1 Synapses in the Hippocampus.海马体中SC-CA1突触处诱导长时程增强需要代谢型谷氨酸受体7的激活。
J Neurosci. 2015 May 13;35(19):7600-15. doi: 10.1523/JNEUROSCI.4543-14.2015.
10
Low-frequency stimulation induces a new form of LTP, metabotropic glutamate (mGlu5) receptor- and PKA-dependent, in the CA1 area of the rat hippocampus.低频刺激在大鼠海马体的CA1区域诱导出一种新形式的长时程增强(LTP),该过程依赖于代谢型谷氨酸(mGlu5)受体和蛋白激酶A(PKA)。
Hippocampus. 2006;16(4):345-60. doi: 10.1002/hipo.20146.

引用本文的文献

1
Hippocampal Inhibitory Interneuron-Specific DREADDs Treatment Alters mTORC1-4E-BP Signaling and Impairs Memory Formation.海马抑制性中间神经元特异性设计药物激活的 Designer Receptors Exclusively Activated by Designer Drugs(DREADDs)治疗会改变mTORC1-4E-BP信号通路并损害记忆形成。
J Neurochem. 2025 Mar;169(3):e70048. doi: 10.1111/jnc.70048.
2
Comparative assessment of the effects of DREADDs and endogenously expressed GPCRs in hippocampal astrocytes on synaptic activity and memory.对海马星形胶质细胞中DREADDs和内源性表达的G蛋白偶联受体对突触活动和记忆的影响进行比较评估。
Front Cell Neurosci. 2023 Mar 27;17:1159756. doi: 10.3389/fncel.2023.1159756. eCollection 2023.
3
Metabotropic glutamate receptor 3 as a potential therapeutic target for psychiatric and neurological disorders.代谢型谷氨酸受体 3 作为精神和神经疾病的潜在治疗靶点。
Pharmacol Biochem Behav. 2022 Nov;221:173493. doi: 10.1016/j.pbb.2022.173493. Epub 2022 Nov 17.
4
Advances in translating mGlu and mGlu receptor selective allosteric modulators as breakthrough treatments for affective disorders and alcohol use disorder.作为治疗情感障碍和酒精使用障碍的突破性疗法,mGlu 和 mGlu 受体选择性变构调节剂的转化研究进展。
Pharmacol Biochem Behav. 2022 Sep;219:173450. doi: 10.1016/j.pbb.2022.173450. Epub 2022 Aug 18.
5
Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia.开发治疗精神分裂症相关神经认知缺陷药物的进展与挑战。
CNS Drugs. 2022 Aug;36(8):819-858. doi: 10.1007/s40263-022-00935-z. Epub 2022 Jul 13.
6
Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 Duplication syndrome.探索 II 型代谢型谷氨酸受体在雷特综合征和 MECP2 重复综合征小鼠模型中的调节作用。
Neuropharmacology. 2022 May 15;209:109022. doi: 10.1016/j.neuropharm.2022.109022. Epub 2022 Mar 3.
7
Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders.靶向代谢型谷氨酸受体治疗抑郁症和其他与应激相关的障碍。
Neuropharmacology. 2021 Sep 15;196:108687. doi: 10.1016/j.neuropharm.2021.108687. Epub 2021 Jun 25.
8
The Unexplored Territory of Neural Models: Potential Guides for Exploring the Function of Metabotropic Neuromodulation.神经模型的未知领域:探索代谢型神经调节功能的潜在指南。
Neuroscience. 2021 Feb 21;456:143-158. doi: 10.1016/j.neuroscience.2020.03.048. Epub 2020 Apr 8.
9
Developing neuroscience-based treatments for alcohol addiction: A matter of choice?基于神经科学的酒精成瘾治疗方法的发展:一种选择?
Transl Psychiatry. 2019 Oct 8;9(1):255. doi: 10.1038/s41398-019-0591-6.
10
Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors.从 mGlu 受体的变构调节中获得神经药理学的新见解。
Trends Pharmacol Sci. 2019 Apr;40(4):240-252. doi: 10.1016/j.tips.2019.02.006. Epub 2019 Feb 26.

本文引用的文献

1
Astrocytic β2-adrenergic receptors mediate hippocampal long-term memory consolidation.星形胶质细胞的β2-肾上腺素能受体介导海马体长期记忆巩固。
Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):8526-31. doi: 10.1073/pnas.1605063113. Epub 2016 Jul 8.
2
Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents.发现一种对代谢型谷氨酸受体亚型3具有选择性且能穿透中枢神经系统的负变构调节剂,在啮齿动物中具有抗抑郁和抗焦虑活性。
J Med Chem. 2015 Sep 24;58(18):7485-500. doi: 10.1021/acs.jmedchem.5b01005. Epub 2015 Sep 10.
3
β-Adrenergic receptor signaling and modulation of long-term potentiation in the mammalian hippocampus.β-肾上腺素能受体信号传导与哺乳动物海马体中长期增强效应的调节
Learn Mem. 2015 Aug 18;22(9):461-71. doi: 10.1101/lm.031088.113. Print 2015 Sep.
4
Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction.代谢型谷氨酸受体3的激活是内侧前额叶皮质长期抑制和恐惧消退所必需的。
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1196-201. doi: 10.1073/pnas.1416196112. Epub 2015 Jan 12.
5
Neuronal transgene expression in dominant-negative SNARE mice.显性负性SNARE小鼠中的神经元转基因表达。
J Neurosci. 2014 Dec 10;34(50):16594-604. doi: 10.1523/JNEUROSCI.2585-14.2014.
6
Propranolol-induced Impairment of Contextual Fear Memory Reconsolidation in Rats: A similar Effect on Weak and Strong Recent and Remote Memories.普萘洛尔对大鼠情境性恐惧记忆再巩固的损害:对近期和远期的弱记忆与强记忆有相似影响。
Basic Clin Neurosci. 2014 Summer;5(3):231-9.
7
Noradrenergic regulation of fear and drug-associated memory reconsolidation.去甲肾上腺素能对恐惧及药物相关记忆再巩固的调节
Neuropsychopharmacology. 2015 Mar;40(4):793-803. doi: 10.1038/npp.2014.243. Epub 2014 Sep 12.
8
PQ-69, a novel and selective adenosine A1 receptor antagonist with inverse agonist activity.PQ-69,一种具有反向激动剂活性的新型选择性腺苷A1受体拮抗剂。
Purinergic Signal. 2014 Dec;10(4):619-29. doi: 10.1007/s11302-014-9424-5. Epub 2014 Sep 24.
9
An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex.大脑皮层神经胶质细胞、神经元和血管细胞的 RNA 测序转录组和剪接数据库。
J Neurosci. 2014 Sep 3;34(36):11929-47. doi: 10.1523/JNEUROSCI.1860-14.2014.
10
The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.代谢型谷氨酸2/3受体激动剂LY379268可抵消氯胺酮和阿扑吗啡诱导的大鼠在物体识别任务而非物体定位任务中的行为表现缺陷。
Neuropharmacology. 2014 Oct;85:27-35. doi: 10.1016/j.neuropharm.2014.05.008. Epub 2014 May 20.

代谢型谷氨酸受体 3 和β-肾上腺素能受体的共激活调节环 AMP 和长时程增强,并破坏记忆再巩固。

Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation.

机构信息

Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.

Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA.

出版信息

Neuropsychopharmacology. 2017 Dec;42(13):2553-2566. doi: 10.1038/npp.2017.136. Epub 2017 Jun 30.

DOI:10.1038/npp.2017.136
PMID:28664928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5686489/
Abstract

Activation of β-adrenergic receptors (βARs) enhances both the induction of long-term potentiation (LTP) in hippocampal CA1 pyramidal cells and hippocampal-dependent cognitive function. Interestingly, previous studies reveal that coincident activation of group II metabotropic glutamate (mGlu) receptors with βARs in the hippocampal astrocytes induces a large increase in cyclic-AMP (cAMP) accumulation and release of adenosine. Adenosine then acts on A adenosine receptors at neighboring excitatory Schaffer collateral terminals, which could counteract effects of activation of neuronal βARs on excitatory transmission. On the basis of this, we postulated that activation of the specific mGlu receptor subtype that mediates this response could inhibit βAR-mediated effects on hippocampal synaptic plasticity and cognitive function. Using novel mGlu receptor subtype-selective allosteric modulators along with knockout mice we now report that the effects of mGlu agonists on βAR-mediated increases in cAMP accumulation are exclusively mediated by mGlu. Furthermore, mGlu activation inhibits the ability of the βAR agonist isoproterenol to enhance hippocampal LTP, and this effect is absent in slices treated with either a glial toxin or an adenosine A receptor antagonist. Finally, systemic administration of the mGlu agonist LY379268 disrupted contextual fear memory in a manner similar to the effect of the βAR antagonist propranolol, and this effect was reversed by the mGlu-negative allosteric modulator VU0650786. Taken together, these data suggest that mGlu can influence astrocytic signaling and modulate βAR-mediated effects on hippocampal synaptic plasticity and cognitive function.

摘要

β-肾上腺素能受体(βAR)的激活增强了海马 CA1 锥体神经元中长时程增强(LTP)的诱导和海马依赖的认知功能。有趣的是,先前的研究表明,海马星形胶质细胞中βAR 与 II 组代谢型谷氨酸(mGlu)受体的同时激活会导致环腺苷酸(cAMP)积累和腺苷释放的大量增加。然后,腺苷在邻近的兴奋性 Schaffer 侧支末端作用于 A 腺苷受体,这可能抵消神经元βAR 对兴奋性传递的激活作用。基于此,我们假设激活介导这种反应的特定 mGlu 受体亚型可以抑制βAR 对海马突触可塑性和认知功能的影响。使用新型 mGlu 受体亚型选择性变构调节剂和基因敲除小鼠,我们现在报告说,mGlu 激动剂对βAR 介导的 cAMP 积累增加的影响完全由 mGlu 介导。此外,mGlu 的激活抑制了βAR 激动剂异丙肾上腺素增强海马 LTP 的能力,而在用神经胶质毒素或腺苷 A 受体拮抗剂处理的切片中,这种作用不存在。最后,系统给予 mGlu 激动剂 LY379268 以类似于βAR 拮抗剂普萘洛尔的方式破坏情境恐惧记忆,而这种作用被 mGlu 负变构调节剂 VU0650786 逆转。总之,这些数据表明 mGlu 可以影响星形胶质细胞信号传导,并调节βAR 对海马突触可塑性和认知功能的影响。